From the December 2021 Quarterly (prominently featured as the second point, second only to the IHL-42X trial timeline)
"commences preparation of US Pre-IND meeting package for IHL-42X".
My opinion on this - we could very well receive an update on this quite soon, as it would make complete sense to align any/all pertinent IHL-42X announcements into a condensed time frame to maximise interest in the program.
I also do not believe the company would bother proceeding with US Pre-IND meeting packages if they weren't bullish on the efficacy of the drug in question (on top of the other bullish signs, being: setting up US network, converting options with their own hard earned etc).
Looking forward to tomorrow.
- Forums
- ASX - By Stock
- IHL
- Ann: Trading Halt
Ann: Trading Halt, page-99
-
- There are more pages in this discussion • 93 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
UNT
UNITH LTD
Idan Schmorak, CEO
Idan Schmorak
CEO
Previous Video
Next Video
SPONSORED BY The Market Online